Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: August 5, 2025
Reporting Period: This filing reports on events occurring on August 5, 2025, specifically regarding upcoming investor presentations.
Financial Metrics
This Form 8-K does not contain specific financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves as a disclosure notice for an investor presentation rather than a financial results report.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated August 2025) for upcoming meetings with investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms upcoming presentations to representatives of investors and analysts.
Regulatory Disclosure: The information provided, including the attached investor presentation, is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Investor Presentation dated August 2025) for actual financial data and strategic outlook, as this 8-K only references the document.
- Confirm the dates and details of the upcoming investor presentations mentioned by executive officers.
- Note that the information in this filing is not legally "filed" under Section 18 of the Exchange Act and carries different liability standards than a standard 10-K or 10-Q.